SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950115-00-000516
Filing Date
2000-04-07
Accepted
2000-04-07 00:00:00
Documents
1
Period of Report
2000-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 4 12074
  Complete submission text file 0000950115-00-000516.txt   13813
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Subject) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 595720
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 1849 YONGE ST SUITE 10 TORONTO M45 1Y2 CANADA